CRP and endometrial cancer: As part of the conducted case–control study, an attempt was made to establish the relationship between CRP, IL-6, IL-1RA (interleukin 1 receptor antagonist), and the degree to which these variables are associated with the risk of obesity and endometrial cancer [93,94].